Literature DB >> 19622256

The management of a patient with an operable carcinoma of the oesophagus.

Tom Crosby1, Mererid Evans, Richard S Gillies, Nicholas D Maynard.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19622256      PMCID： PMC2758428          DOI： 10.1308/003588409X432428

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


× No keyword cloud information.
  18 in total

1.  Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

2.  A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.

Authors:  John D Urschel; Hari Vasan
Journal:  Am J Surg       Date:  2003-06       Impact factor: 2.565

Review 3.  Postoperative mortality following oesophagectomy and problems in reporting its rate.

Authors:  G G Jamieson; G Mathew; R Ludemann; J Wayman; J C Myers; P G Devitt
Journal:  Br J Surg       Date:  2004-08       Impact factor: 6.939

4.  Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.

Authors:  D P Kelsen; R Ginsberg; T F Pajak; D G Sheahan; L Gunderson; J Mortimer; N Estes; D G Haller; J Ajani; W Kocha; B D Minsky; J A Roth
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

5.  Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.

Authors:  J Rüdiger Siewert; M Feith; M Werner; H J Stein
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

6.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

7.  Micrometastases in esophagogastric cancer: high detection rate in resected rib segments.

Authors:  G C O'sullivan; D Sheehan; A Clarke; R Stuart; J Kelly; M D Kiely; T Walsh; J K Collins; F Shanahan
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

Review 8.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

9.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.

Authors:  Jan B F Hulscher; Johanna W van Sandick; Angela G E M de Boer; Bas P L Wijnhoven; Jan G P Tijssen; Paul Fockens; Peep F M Stalmeier; Fiebo J W ten Kate; Herman van Dekken; Huug Obertop; Hugo W Tilanus; J Jan B van Lanschot
Journal:  N Engl J Med       Date:  2002-11-21       Impact factor: 91.245

10.  Oxford experience with neoadjuvant chemotherapy and surgical resection for esophageal adenocarcinomas and squamous cell tumors.

Authors:  P M Safranek; V Sujendran; R Baron; N Warner; C Blesing; N D Maynard
Journal:  Dis Esophagus       Date:  2008       Impact factor: 3.429
View more
  9 in total

1.  The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma.

Authors:  Shao-bin Chen; Hong-rui Weng; Geng Wang; Di-tian Liu; Hua Li; Hao Zhang; Yu-ping Chen
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-02       Impact factor: 4.553

Review 2.  Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a review.

Authors:  Yijun Luo; Xiaoli Wang; Jinming Yu; Bin Zhang; Minghuan Li
Journal:  Tumour Biol       Date:  2016-09-18

Review 3.  Oesophageal cancer--an overview.

Authors:  Michael Schweigert; Attila Dubecz; Hubert J Stein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-08       Impact factor: 46.802

4.  Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Authors:  R S Gillies; M R Middleton; C Blesing; K Patel; N Warner; R E K Marshall; N D Maynard; K M Bradley; F V Gleeson
Journal:  Eur Radiol       Date:  2012-05-05       Impact factor: 5.315

Review 5.  Lymphatic spreading and lymphadenectomy for esophageal carcinoma.

Authors:  Xiang Ji; Jie Cai; Yao Chen; Long-Qi Chen
Journal:  World J Gastrointest Surg       Date:  2016-01-27

6.  Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.

Authors:  Fei Zhou; Meiling Zhu; Mengyun Wang; Lixin Qiu; Lei Cheng; Ming Jia; Jiaqing Xiang; Qingyi Wei
Journal:  J Transl Med       Date:  2016-05-31       Impact factor: 5.531

7.  The expression of aplysia ras homolog I (ARHI) and its inhibitory effect on cell biological behavior in esophageal squamous cell carcinoma.

Authors:  Yuqiang Mao; Yun Han; Wenjun Shi
Journal:  Onco Targets Ther       Date:  2017-02-27       Impact factor: 4.147

8.  Endoscopic Submucosal Dissection Followed by Concurrent Chemoradiotherapy in Patients with Early Esophageal Cancer with a High Risk of Lymph Node Metastasis.

Authors:  Hee Kyung Kim; Weon Jin Ko; Chang-Il Kwon; Ga Won Song; In Kyun Yoo; Ji Hyun Song; Hak Su Kim; Joo Young Cho
Journal:  Clin Endosc       Date:  2019-05-14

9.  Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients.

Authors:  Hongwu Zhu; Xiong Chen; Bin Chen; Bei Chen; Weibing Song; Dayong Sun; Yagang Zhao
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.